|
US3981997A
|
|
Analgesic compositions comprising 1H- or respectively 2H-indazolone-3 (β-morpholino-alkoxy) compounds
|
|
DE2508203A1
|
|
1,1,Diphenyl-2-tert-amino-propan-1-ol diuretics and saluretics - esp. 2-piperidino and 2-pyrrolidino cpds. having low kaliuretic activity
|
|
DE2410284A1
|
|
1,1,Diphenyl-2-tert-amino-propan-1-ol diuretics and saluretics - esp. 2-piperidino and 2-pyrrolidino cpds. having low kaliuretic activity
|
|
US3899488A
|
|
2H-indazolone compound
|
|
DE2147066A1
|
|
Urinary calcium selective determination - with sodium ethylene diamine tetraacetate and indicator in presence of microcrystalline ce
|
|
NL169469B
|
|
Method for preparing indazolic compounds and their salts, and analgetic medicinal products containing this type of indazolic compounds.
|
|
GB1333618A
|
|
Processes for producing 1-h or 2-h-indazolone-3 derivatives
|
|
GB1333619A
|
|
Pharmaceutical compositions comprising 1-h or 2-h-indazolone-3 derivatives
|
|
GB945162A
|
|
Improvements in or relating to the preparation of aryl alkyl aminoketones
|
|
US3001910A
|
|
Anorexigenic propiophenones
|
|
ES241343A1
|
|
Procedure for the manufacture of a product for the treatment of ores obesity (Machine-translation by Google Translate, not legally binding)
|
|
GB849755A
|
|
Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
|
|
DE658958C
|
|
Process for obtaining the total pigment substances in turmeric drugs
|
|
CA642241A
|
|
Physiologically active amines
|
